Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -404.67% is 47% below its 4-year average of -275.93%, around the middle of its 4-year range (-649.31%–-116.36%).
140.67% below its 12-month average of -168.15%.
Reported quarterly return on assets; no daily interpolation. Q1 FY2027 (2026-06-30): -68.54%.
RETURN ON ASSETS (ROA)
-404.67%
RETURN ON ASSETS (ROA) AVG TTM
-168.15%
RETURN ON ASSETS (ROA) AVG 3Y
-182.58%
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-140.67%
CURRENT VS 3Y AVG
-121.64%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-24.95%
median of 438 covered companies
CURRENT VS SECTOR MEDIAN
-1521.92%
vs the sector median at left
Autonomix Medical, Inc.
Market Cap
$1.92M
Return on Assets (ROA)
-404.67%
TTM Avg
-168.15%
3Y Avg
-182.58%
5Y Avg
N/A
Market Cap
$1.54M
Return on Assets (ROA)
-111.51%
TTM Avg
-71.56%
3Y Avg
-64.13%
5Y Avg
-49.86%
Market Cap
$2.36M
Return on Assets (ROA)
-439.95%
TTM Avg
-322.44%
3Y Avg
-242.34%
5Y Avg
-192.54%
Market Cap
$1.49M
Return on Assets (ROA)
-36.88%
TTM Avg
-64.67%
3Y Avg
-76.84%
5Y Avg
-289.12%
Market Cap
$2.37M
Return on Assets (ROA)
-64.42%
TTM Avg
-79.57%
3Y Avg
-65.34%
5Y Avg
-858.61%
Market Cap
$1.37M
Return on Assets (ROA)
-96.27%
TTM Avg
-335.81%
3Y Avg
-263.87%
5Y Avg
-193.48%
Market Cap
$2.47M
Return on Assets (ROA)
-228.77%
TTM Avg
-130.86%
3Y Avg
-126.84%
5Y Avg
-140.90%
Market Cap
$1.36M
Return on Assets (ROA)
-196.18%
TTM Avg
-334.48%
3Y Avg
-197.38%
5Y Avg
-169.68%
Market Cap
$2.59M
Return on Assets (ROA)
-199.30%
TTM Avg
-137.41%
3Y Avg
-109.57%
5Y Avg
-977.62%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Autonomix Medical, Inc. (AMIX) | $1.92M | -404.67% | -168.15% | -182.58% | N/A |
| Curis, Inc. (CRIS)vs › | $1.54M | -111.51% | -71.56% | -64.13% | -49.86% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.36M | -439.95% | -322.44% | -242.34% | -192.54% |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | -36.88% | -64.67% | -76.84% | -289.12% |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.37M | -64.42% | -79.57% | -65.34% | -858.61% |
| Genprex, Inc. (GNPX)vs › | $1.37M | -96.27% | -335.81% | -263.87% | -193.48% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.47M | -228.77% | -130.86% | -126.84% | -140.90% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.36M | -196.18% | -334.48% | -197.38% | -169.68% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.59M | -199.30% | -137.41% | -109.57% | -977.62% |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | -64.99% | -31.34% | -98.36% | -79.15% |
ROA
-404.7%
ROE
-509.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-03-31 | -219.93% |
| 2025-03-31 | -116.36% |
| 2024-03-31 | -163.98% |
| 2023-03-31 | -230.06% |
| 2022-03-31 | -649.31% |
